Home > Cardiology > Survival higher after septal myectomy vs alcohol ablation for hypertrophic cardiomyopathy

Survival higher after septal myectomy vs alcohol ablation for hypertrophic cardiomyopathy

Journal
 Journal of the American College of Cardiology
Reuters Health - 20/05/2022 - Among patients requiring septal reduction procedures for symptomatic hypertrophic cardiomyopathies (HCM), long-term all-cause mortality was higher after alcohol septal ablation (ASA) than after septal myectomy (SM) at three major HCM centers with highly experienced physicians. The patients were treated between 1998 and 2019 at the Mayo Clinic in Rochester, Minnesota, Tufts Medical Center in Boston, and Fuwai Hospital in Beijing, China. Researchers reviewed data on 3,359 patients: 3,274 who received SM and 585 who had ASA. Over a median of 6.4 years (IQR: 3.6-10.2 years), the 10 year all-cause mortality was 26.1% in the ASA group and 8.2% in the myectomy group, according to a report in the Journal of the American College of Cardiology by Dr. Hao Cui of the Mayo Clinic and colleagues. Their analysis showed significant differences in the baseline characteristics of the patients, with rates of many risk factors increased in the ASA v...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on